Alaunos Therapeutics (TCRT) Profit After Tax (2009 - 2026)
Alaunos Therapeutics (TCRT) reported Profit After Tax of -$1.0 million for Q1 2026, up 6.24% on a YoY basis from -$946875.4 in Q1 2025, and down 12.65% quarter-over-quarter from -$893000.0 in Q4 2025.
Alaunos Therapeutics (TCRT) Profit After Tax (2009 - 2026) Analysis & Trends
Alaunos Therapeutics has reported Profit After Tax for 18 years, with the latest figure at -$1.0 million in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax rose 6.24% year-over-year to -$1.0 million; the trailing twelve-month figure through Mar 2026 stood at -$4.1 million (down 0.93% YoY), and the FY2025 full-year result was -$4.2 million, up 10.75% from the prior year.
- Profit After Tax for Q1 2026 stood at -$1.0 million, down from -$893000.0 in the prior quarter.
- The five-year high for Profit After Tax was $22.6 million in Q4 2023, with the low at -$10.0 million in Q1 2023.
- Historically, Profit After Tax has averaged -$3.1 million across 5 years, with a median of -$1.2 million in 2025.
- Annual changes were most pronounced in 2023 — Profit After Tax surged 346.95% — and 2024, when it sank 103.28%.
- Alaunos Therapeutics' Profit After Tax stood at -$9.2 million in 2022, then soared by 346.95% to $22.6 million in 2023, then sank by 103.28% to -$742000.0 in 2024, then fell by 20.35% to -$893000.0 in 2025, then retreated by 12.65% to -$1.0 million in 2026.
- The last three Profit After Tax figures came in at -$1.0 million (Q1 2026), -$893000.0 (Q4 2025), and -$1.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.63 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.74 Mn |
| 10 | Alaunos Therapeutics | 4.31 Mn | 3.95 Mn | - | -1.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.01 Mn |
| Dec 31, 2025 | -893,000.00 |
| Sep 30, 2025 | -1.16 Mn |
| Jun 30, 2025 | -1.05 Mn |
| Mar 31, 2025 | -1.07 Mn |
| Dec 31, 2024 | -742,000.00 |
| Sep 30, 2024 | -1.13 Mn |
| Jun 30, 2024 | -1.13 Mn |
| Mar 31, 2024 | -1.68 Mn |
| Dec 31, 2023 | 22.62 Mn |
| Sep 30, 2023 | -8.48 Mn |
| Jun 30, 2023 | -8.77 Mn |
| Mar 31, 2023 | -10.05 Mn |
| Dec 31, 2022 | -9.16 Mn |
| Sep 30, 2022 | -8.85 Mn |
| Jun 30, 2022 | -9.93 Mn |
| Mar 31, 2022 | -9.79 Mn |
| Dec 31, 2021 | -11.79 Mn |
| Sep 30, 2021 | -22.73 Mn |
| Jun 30, 2021 | -22.67 Mn |